<DOC>
	<DOCNO>NCT00192036</DOCNO>
	<brief_summary>The purpose study evaluate response rate patient non small lung cancer gemcitabine combination radiotherapy . The tolerability safety combination also evaluate .</brief_summary>
	<brief_title>Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy Treatment Inoperable Stage III Non Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Inoperable non small cell lung cancer Stage III Adequate hematological parameter Adequate Lung function reserve Previous chemotherapy thoracic radiation non small cell lung cancer Presence distant metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>